Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial
Por:
Cai, AP, Bayes-Genis, A, Ryan, J, Feng, YQ, Januzzi, JL, Tonkin, AM, Zheng, JZ, Nelson, MR, Neumann, JT, Woods, RL, Tran, C, Schutte, AE, Pandey, A, Chen, LY, Liu, L, Zhang, JG, Mcneil, JJ, Beilin, L, Tes, HF, Parati, G and Zhou, Z
Publicada:
9 dic 2025
Ahead of Print:
22 oct 2025
Resumen:
BACKGROUND: Blood pressure (BP) management in older adults is complex because of age-related physiological changes and uncertainty around ideal systolic BP (SBP) targets. Heart stress (HS), defined by age-adjusted elevation in NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels, may improve cardiovascular disease (CVD) risk stratification and support more individualized BP management. METHODS: We conducted a post hoc analysis of ASPREE (Aspirin in Reducing Events in the Elderly) involving 11 941 community-dwelling older adults without CVD at enrollment (mean age, 75.1 years; 53.5% women). HS was defined by NT-proBNP >= 150 pg/mL for participants 65 to 74 years of age and >= 300 pg/mL for participants >= 75 years of age. Participants were categorized into 4 groups by hypertension and HS status. The primary outcome was total CVD events (a composite of nonfatal myocardial infarction, fatal or nonfatal stroke, coronary heart disease death, or hospitalization for heart failure). Associations between hypertension and SBP with total CVD events were examined by HS status using Cox proportional-hazards models and restricted cubic spline. SBP was evaluated categorically (<120, 120-129, 130-139, 140-159, or >= 160 mm Hg) and continuously. A landmark sensitivity analysis excluded participants with CVD events or censoring in the first 2 years, with follow-up starting at year 3. RESULTS: HS was present in 25.8% of participants. Compared with the reference group (no hypertension or HS), adjusted hazard ratios (95% CI) for total CVD events were 1.41 (1.18-1.70) for hypertension + no HS, 1.79 (1.34-2.39) for no hypertension + HS, and 2.32 (1.89-2.84) for hypertension + HS (P-trend<0.001). Among participants without HS, the lowest incidence of total CVD events occurred at SBP 130 to 139 mm Hg, showing a U-shaped association across SBP levels (P-non(linearity)=0.011). Among participants with HS, risk increased linearly with SBP (P-linear (trend)=0.85) and was lowest at SBP <120 mm Hg. Landmark analyses yielded generally consistent findings. CONCLUSIONS: HS is common in older adults and jointly associated with hypertension and increased CVD risk. The SBP-CVD relationship differs by HS status, suggesting a potential value of HS for guiding individualized BP management. Prospective studies are warranted to determine whether HS-guided strategies improve BP control and reduce CVD risk in older adults.
Filiaciones:
Cai, AP:
Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Hypertens Res Lab, Dept Cardiol,Guangdong Cardiovasc Inst, Guangzhou, Peoples R China
:
Hosp Univ Germans Trias i Pujol, Heart Inst, CIBERCV, Badalona, Spain
Ryan, J:
Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
Feng, YQ:
Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Hypertens Res Lab, Dept Cardiol,Guangdong Cardiovasc Inst, Guangzhou, Peoples R China
Januzzi, JL:
Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA USA
Baim Inst Clin Res, Boston, MA USA
Tonkin, AM:
Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
Zheng, JZ:
Hong Kong Univ Sci & Technol Guangzhou, Biosci & Biomed Engn Thrust, Syst Hub, Guangzhou, Guangdong, Peoples R China
Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou, Peoples R China
Nelson, MR:
Univ Tasmania, Menzies Inst Med Res, Hobart, Australia
Neumann, JT:
Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
Univ Heart & Vasc Ctr UHZ, Dept Cardiol, Hamburg, Germany
German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany
Woods, RL:
Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
Tran, C:
Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
Schutte, AE:
Univ New South Wales, George Inst Global Hlth, Sch Populat Hlth, Sydney, Australia
Pandey, A:
Univ Texas Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX USA
Chen, LY:
Univ Minnesota, Lillehei Heart Inst, Med Sch, Cardiovasc Div, Minneapolis, MN USA
Univ Minnesota, Med Sch, Dept Med, Cardiovasc Div, Minneapolis, MN USA
Liu, L:
Univ Hong Kong, Sch Clin Med, Dept Med, Hong Kong, Peoples R China
Mcneil, JJ:
Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
Beilin, L:
Univ Western Australia, Med Sch, Perth, Australia
Tes, HF:
Univ Hong Kong, Sch Clin Med, Dept Med, Hong Kong, Peoples R China
Parati, G:
Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
Dept Univ Milano Bicocca Cardiol, San Luca Hosp, Ist Auxol Italiano, IRCCS, Milan, Italy
Zhou, Z:
Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
Green Submitted
|